This GCN5-USP1-PARP1 axis provides novel insights into the role of acetyltransferases and deubiquitinases in CCA pathogenesis and may pave the way for developing improved targeted therapies against this deadly disease. This evidence concerns the gene PARP1 and cholangiocarcinoma.